Niaid process and analytical support for development of HIV vaccines

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN272201600011I
Awardee
Awarding agency
Task orders
14 $11,614,179 obligated

Award facts

Opportunity
Combined order value
  • $11,614,179 Current, with exercised options
  • $20,558,853 Potential, with all options
Last date to order 100% complete
IDV ceiling 12% used
$98,587,183.00
Maximum order
$98,587,183.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, to provide a range of research, development, manufacturing, and advocacy services to advance the creation and delivery of vaccines and antibodies for infectious diseases. The contract, valued at up to $98.6 million, has a period of performance ending on July 31, 2026.

Under this IDC, NIAID has issued multiple task orders to IAVI to support the development of HIV vaccine candidates, including process development, analytical testing, cGMP manufacturing, regulatory support, and other activities. The task orders have values ranging from $110,751 to $3.2 million and utilize a cost-plus-fixed-fee pricing structure. IAVI has partnered with various subcontractors, including universities and biotechnology companies, to leverage specialized expertise across the product development lifecycle. This work aligns with NIAID's broader efforts to advance promising vaccine, therapeutic, and diagnostic candidates for infectious diseases like HIV through preclinical and clinical testing.

Task orders

Task order Ordering agency Obligated Awarded
This task order is to develop an optimized phase 1 cgmp manufacturing process for lipid nanoparticle (LNP)… 75N93021F00239 National Institute of Allergy and Infectious Diseases (NIH) $2,250,342
Coordination and technical support 75N93021F00240 National Institute of Allergy and Infectious Diseases (NIH) $177,790
Coordination and technical support 75N93020F00001 National Institute of Allergy and Infectious Diseases (NIH) $256,138
Antigen-adjuvant formulation and characterization studies 75N93019F00270 National Institute of Allergy and Infectious Diseases (NIH) $978,729
Nanoparticle-based development for HIV-1 biomolecule delivery 75N93019F00257 National Institute of Allergy and Infectious Diseases (NIH) $713,686
Process development for cell culture, upstream and downstream process in production of HIV-1 biomolecules 75N93019F00269 National Institute of Allergy and Infectious Diseases (NIH) $1,707,175
Process and assay development for cgmp production and characterization of a VSV candidate 75N93019F00132 National Institute of Allergy and Infectious Diseases (NIH) $859,745
Coordination and technical support 75N93019F00131 National Institute of Allergy and Infectious Diseases (NIH) $299,063
Product development plans to support HIV vaccine manufacturing efforts HHSN27200005 National Institute of Allergy and Infectious Diseases (NIH) $105,353
Product development plans to support HIV vaccine manufacturing efforts HHSN27200006 National Institute of Allergy and Infectious Diseases (NIH) $110,751
To DE-obligate remaining 2017 funds. HHSN27200004 National Institute of Allergy and Infectious Diseases (NIH) $432,452
Analysis of HIV-1 ENV host cell proteins by mass spectrometry method HHSN27200003 National Institute of Allergy and Infectious Diseases (NIH) $508,433
To DE-obligate remaining FY 2017 funds. HHSN27200002 National Institute of Allergy and Infectious Diseases (NIH) $1,572,742
Coordination and technical support HHSN27200001 National Institute of Allergy and Infectious Diseases (NIH) $1,641,780
Show all 14

Transactions

Action Obligated Date
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action 1 $0
Original award $0
Show all 11

Quick answers

Who was awarded contract HHSN272201600011I?

HHSN272201600011I was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2016.

How much is contract HHSN272201600011I worth?

Orders under HHSN272201600011I have obligated $11,614,179. Their combined potential value, with all options, is $20,558,853. HHSN272201600011I's own ceiling is $98,587,183. A single order can be worth up to $98,587,183.

How many orders have been placed under contract HHSN272201600011I?

14 orders have been placed under HHSN272201600011I, the latest on September 15, 2021.

Who can order from contract HHSN272201600011I?

HHSN272201600011I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN272201600011I competed?

The extent of competition for HHSN272201600011I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV